A. Kapur

发表

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

J. Gonzalez-Bosquet, M. Patankar, S. Horibata, 2014, Molecular Cancer.

Identification of Unique Clusters of T, Dendritic and Innate Lymphoid Cells in the Peritoneal Fluid of Ovarian Cancer Patients.

M. Patankar, L. Barroilhet, J. Vazquez, 2020, American journal of reproductive immunology.

MUC16 suppresses human and murine innate immune responses.

M. Patankar, S. Gillies, J. Connor, 2019, Gynecologic oncology.

MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells

C. Rancourt, M. Patankar, S. Horibata, 2010, Molecular Cancer.

Trans10,cis12 conjugated linoleic acid inhibits proliferation and migration of ovarian cancer cells by inducing ER stress, autophagy, and modulation of Src

Matthew L. Anderson, M. Patankar, M. Cook, 2018, PloS one.

RT-SVR+q: a strategy for post-Mascot analysis using retention time and q value metric to improve peptide and protein identifications.

M. Patankar, Lingjun Li, Yadi Ma, 2011, Journal of proteomics.

Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface

M. Patankar, S. Horibata, S. Gillies, 2011, Cancer Immunology, Immunotherapy.

Research of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes

C. Rancourt, J. Paulson, M. Patankar, 2010 .

Modulation of oxidative stress and subsequent induction of apoptosis and endoplasmic reticulum stress allows citral to decrease cancer cell proliferation

M. Patankar, May P. Xiong, R. Whelan, 2016, Scientific Reports.

Formulation, Characterization, and Antitumor Properties of Trans- and Cis-Citral in the 4T1 Breast Cancer Xenograft Mouse Model

M. Patankar, May P. Xiong, A. Kapur, 2015, Pharmaceutical Research.

DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1

J. Connor, M. Felder, A. Kapur, 2012, BMC Cancer.

Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers

Sean P. Palecek, Spencer S. Ericksen, S. Palecek, 2022, Cancers.

Oxidative stress induced by the anti-cancer agents, plumbagin, and atovaquone, inhibits ion transport through Na+/K+-ATPase

M. Patankar, B. Pattnaik, Yousef M. Alharbi, 2020, Scientific Reports.

Pregnancy Ameliorates the Inhibitory Effects of 2-Methoxyestradiol on Angiogenesis in Primary Sheep Uterine Endothelial Cells

R. Magness, S. Salih, S. Salama, 2011, Reproductive Sciences.

Terpenoids from Zingiber officinale (Ginger) Induce Apoptosis in Endometrial Cancer Cells through the Activation of p53

M. Patankar, Yang Liu, D. Kushner, 2012, PloS one.

Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin

Spencer S. Ericksen, M. Patankar, M. Skala, 2018, Scientific Reports.

Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer

Manish S Patankar, M. Patankar, Amruta P Nayak, 2018, Cancers.

Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma.

A. Sood, A. Rajkovic, Wei Hu, 2013, Cancer letters.

Plumbagin-induced oxidative stress leads to inhibition of Na+/K+-ATPase (NKA) in canine cancer cells

M. Patankar, B. Pattnaik, L. Barroilhet, 2019, Scientific Reports.

The detection, treatment, and biology of epithelial ovarian cancer

M. Patankar, J. Connor, A. Kapur, 2010, Journal of ovarian research.

M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor/matrix metalloproteinase 9 intercellular feedback loop

M. Patankar, M. J. Carroll, M. Felder, 2016, Oncotarget.

DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1

J. Connor, M. Felder, A. Kapur, 2012, BMC Cancer.

The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Mahavir Singh, A. Chauhan, A. Kapur, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes

C. Rancourt, J. Paulson, M. Patankar, 2010, Molecular Cancer.

Identifying novel ovarian tumor biomarkers through mining of the transcriptome of circulating immune cells: A proof‐of‐concept study

J. Gonzalez-Bosquet, M. Patankar, L. Barroilhet, 2021, American journal of reproductive immunology.

Differential expression of proteins in naïve and IL-2 stimulated primary human NK cells identified by global proteomic analysis.

M. Patankar, Lingjun Li, Di Ma, 2013, Journal of proteomics.

Effects of Lipopolysaccharide and Mannheimia haemolytica Leukotoxin on Bovine Lung Microvascular Endothelial Cells and Alveolar Epithelial Cells

David Carlton, D. Carlton, C. Czuprynski, 2007, Clinical and Vaccine Immunology.

The Mucin MUC16 (CA125) Binds to NK Cells and Monocytes from Peripheral Blood of Women with Healthy Pregnancy and Preeclampsia

M. Patankar, J. Connor, M. Felder, 2012, American journal of reproductive immunology.

High-Throughput Quantitative Glycomics Enabled by 12-plex Isobaric Multiplex Labeling Reagents for Carbonyl-Containing Compound (SUGAR) Tags.

M. Patankar, Lingjun Li, A. Kapur, 2023, Journal of proteome research.

Plasmonic Nanoparticle-based Digital Cytometry to Quantify MUC16 Binding on the Surface of Leukocytes in Ovarian Cancer.

Lauren A Austin, D. Cramer, M. Patankar, 2020, ACS sensors.

Effects of Extracellular ATP on Bovine Lung Endothelial and Epithelial Cell Monolayer Morphologies, Apoptoses, and Permeabilities

D. Carlton, C. Czuprynski, D. Mcclenahan, 2008, Clinical and Vaccine Immunology.

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

J. Gonzalez-Bosquet, M. Patankar, S. Horibata, 2014, Molecular Cancer.

Formulation, Characterization, and Antitumor Properties of Trans- and Cis-Citral in the 4T1 Breast Cancer Xenograft Mouse Model

M. Patankar, May P. Xiong, A. Kapur, 2015, Pharmaceutical Research.